Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.8M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$131M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Forbion Growth Opportunities Fund I Cooperatief U.A. | Oct 8, 2024 | Buy | 800 | $6.5981 | $5,300 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | Oct 7, 2024 | Buy | 11,844 | $6.546 | $78,000 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | Oct 4, 2024 | Buy | 5,997 | $6.5436 | $39,000 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | Oct 3, 2024 | Buy | 5,769 | $6.4824 | $37,000 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | Oct 2, 2024 | Buy | 10,153 | $6.3722 | $65,000 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | Oct 1, 2024 | Buy | 35,279 | $6.4389 | $230,000 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | Sep 30, 2024 | Buy | 341,332 | $6.338 | $2.2M |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | Sep 27, 2024 | Buy | 38,396 | $5.9384 | $230,000 |
| Cooper Ronald Harold Wilfred | Sep 27, 2024 | Buy | 10,000 | $5.7 | $57,000 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | Sep 27, 2024 | Buy | 3,243 | $6.3794 | $21,000 |
| FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | Apr 22, 2024 | Sell | 47,854 | $15 | $720,000 |
| FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | Apr 19, 2024 | Sell | 100 | $15 | $1,500 |
| FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | Apr 18, 2024 | Sell | 4,575 | $15.01 | $69,000 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | Dec 29, 2023 | Buy | 9,620 | $9.0905 | $87,000 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | Dec 29, 2023 | Buy | 400 | $8.3 | $3,300 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | Dec 28, 2023 | Buy | 5,050 | $7.6885 | $39,000 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | Dec 27, 2023 | Buy | 2,750 | $7.1678 | $20,000 |
What's the latest insider transaction for enGenes?
The most recent insider transaction for enGenes was conducted by Forbion Growth Opportunities Fund I Cooperatief U.A., who sold 800 shares on October 8, 2024 at a price of $6.60 per share.
Which insider bought the most ENGN stock over the last two years?
Forbion Growth Opportunities Fund I Cooperatief U.A. has bought the most ENGN stock in the last 2 years, with a total value of $3M.
Which insider has sold the most ENGN stock over the last two years?
FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC has sold the most ENGN stock in the last 2 years, with a total value of $790,000.
What is the total value of insider transactions for enGenes (ENGN) in the last 2 years?
According to our estimates, the total value of insider transactions for enGenes in the last 2 years is positive, amounting to $2.3M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on enGenes' market confidence?
Over the last 2 years, insider transactions for enGenes have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
